STOCK TITAN
  1. Home
  2. Sec-filings
  3. NUS
  4. [Form 4] NU SKIN ENTERPRISES, INC. Insider Trading Activity

Director Mark A. Zorko receives 26,643-share equity grant at NU SKIN (NUS)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Zorko Mark A reported acquisition or exercise transactions in this Form 4 filing.

NU SKIN ENTERPRISES, INC. director Mark A. Zorko received a grant of 26,643 shares of Class A Common Stock on June 1, 2026 at no purchase price. Following this equity award, he directly holds 60,586 shares. This is a compensation-related grant, not an open-market trade.

Positive

  • None.

Negative

  • None.
Insider Zorko Mark A
Role null
Type Security Shares Price Value
Grant/Award Class A Common Stock 26,643 $0.00 --
Holdings After Transaction: Class A Common Stock — 60,586 shares (Direct, null)
Footnotes (1)
Shares granted 26,643 shares Class A Common Stock grant on June 1, 2026
Grant price $0.00 per share Equity award, not open-market purchase
Shares owned after 60,586 shares Total direct holdings following the grant
Transaction code A Grant, award, or other acquisition
Form 4 regulatory
"This Form 4 discloses a share grant, not a market purchase."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Class A Common Stock financial
"received a grant of 26,643 shares of Class A Common Stock on June 1, 2026"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
grant, award, or other acquisition financial
"classified as a grant, award, or other acquisition for compensation"
transaction code "A" regulatory
"Transaction code “A” indicates a grant, award, or other acquisition of securities."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zorko Mark A
(Last)(First)(Middle)
C/O NU SKIN ENTERPRISES, INC.
75 W CENTER STREET
(Street)
PROVO UTAH 84601
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/01/2026A26,643A$0.0060,586D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Gregory Belliston as Attorney-in-Fact for Mark Zorko06/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did NU SKIN (NUS) director Mark A. Zorko report?

Director Mark A. Zorko reported receiving a grant of 26,643 shares of Class A Common Stock. The shares were awarded at no purchase price as compensation, rather than acquired through an open-market transaction, and increase his direct equity stake in the company.

Was the NU SKIN (NUS) Form 4 transaction a stock purchase or a grant?

The Form 4 discloses a share grant, not a market purchase. Mark A. Zorko received 26,643 Class A Common shares at a per-share price of $0.00, classified as a grant, award, or other acquisition for compensation rather than an open-market buy.

How many NU SKIN (NUS) shares does Mark A. Zorko hold after this grant?

After the reported transaction, Mark A. Zorko directly holds 60,586 shares of NU SKIN Class A Common Stock. This total includes the 26,643 shares granted on June 1, 2026, and represents his direct ownership position reported in the Form 4 filing.

What does transaction code "A" mean in the NU SKIN (NUS) Form 4?

Transaction code “A” indicates a grant, award, or other acquisition of securities. In this Form 4, it shows that Mark A. Zorko received 26,643 shares of Class A Common Stock as an equity award, with no cash paid per share in the transaction.

Did NU SKIN (NUS) director Mark A. Zorko sell any shares in this Form 4?

No share sales are reported in this Form 4. The filing shows only an acquisition via grant of 26,643 Class A Common shares, with no transactions coded as sales or dispositions, and total direct holdings increasing to 60,586 shares after the award.